[{"id":"3a35ee83-442b-425a-b135-8f3ccbaaf11f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06559189","created_at":"2025-02-27T08:09:32.925Z","updated_at":"2025-02-27T08:09:32.925Z","phase":"Phase 1","brief_title":"CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL","source_id_and_acronym":"NCT06559189","lead_sponsor":"University of Colorado, Denver","biomarkers":" CD22","pipe":"","alterations":" ","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19x22 CAR T"],"overall_status":"Recruiting","enrollment":" Enrollment 26","initiation":"Initiation: 09/27/2024","start_date":" 09/27/2024","primary_txt":" Primary completion: 12/01/2028","primary_completion_date":" 12/01/2028","study_txt":" Completion: 12/01/2029","study_completion_date":" 12/01/2029","last_update_posted":"2024-10-18"}]